Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response

A technology of molecular patterns and compositions, applied in the field of fusion proteins and polypeptides, and fusion proteins, can solve problems such as inferior immunogenicity, unknown harmful side effects, etc., and achieve effective immunogenicity, reduce side effects, and prevent or treat infections.

Inactive Publication Date: 2008-01-23
VAXINNATE
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, such compositions may be less than optimally immunogenic, may cause unknown hazards if improperly prepared, and may have adverse side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
  • Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
  • Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0229] Materials and methods

[0230] PCR amplification and DNA primers:

[0231] All PCR amplifications were performed using Pfu UltraHotstart PCR master mix (Cat# 600630) from Stratagene (La Jolla, CA) according to the manufacturer's recommendations. DNA primers were purchased from Sigma Genosys and are described below:

[0232] STF28BGF-1:

[0233] CTCGGGAGATCTGCACAAGTAATCAACACTAACAGTCT (SEQ ID NO: 41)

[0234] STF28MCR-1:

[0235] CCATGGGCTAGCAGGATCCACCGGCGCTCCCTGCACGTTCA (SEQ ID NO: 42)

[0236] STF28MCF-2:

[0237] GGAGCGCCGGTGGATCCTGCTAGCCCATGGACCGAAAACCCG (SEQ ID NO: 43)

[0238] STF28ECR-2:

[0239] TCTGCAGAATTCACGTAACAGAGACAGCACGTTCTGCGGGACGTCCCGCAGAACGTGCTGTCTCTGTTACGTGAATTCTGCAGA (SEQ ID NO: 44)

[0240] pET24AR: 5TCCGGCGTAGAGGATCGAGA (Sequence ID: 45)

[0241] STF2-E3R3:

[0242] CAATTGACCTTCAAGCTTCGAATTGCCCTTACGTAACAGAGACAGCACGTTCTG (SEQ ID NO: 46)

[0243] AX-E3F3:

[0244] AAGCTTGAAGGTCAATTGGAATTCCCTAGGACTAGTATGGAAAAATTGCAGTTGAAG (SEQ ID NO: 47)

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

Compositions comprise at least a portion of an antigen and at least a portion of a flagellin that lacks a hinge region. Compositions, fusion proteins and polypeptides comprise at least a portion of at least one pathogen-associated molecular pattern and at least a portion of at least one viral protein. The viral protein of the compositions, fusion proteins and polypeptides of the invention are flaviviral proteins, including a West Nile flaviviral protein, a Dengue flaviviral protein, a Langat flaviviral protein, a Kunjin flaviviral protein, a Murray Valley encephalitis flaviviral protein, a Japanese encephalitis flaviviral protein, a Tick- borne encephalitis flaviviral protein, a Yellow fever flaviviral protein and a hepatitis C flaviviral protein. The compositions, fusion proteins and polypeptides are used to stimulate an immune response in a subject.

Description

[0001] related application [0002] This application claims U.S. Provisional Application Nos. 60 / 645,170, filed January 19, 2005; 60 / 653,405, filed February 15, 2005; 60 / 704,160, filed July 29, 2005 ; No. 60 / 723,409, dated October 4, 2005; and No. 60 / 725,919, dated October 11, 2005. The teachings of the above applications are incorporated herein by reference. Background technique [0003] Infection with viruses including Flaviviruses, e.g., West Nile Flavivirus, Dengue Flavivirus, Japanese Encephalitis Flavivirus, Langat Flavivirus, Kunjin Flavivirus , Murray Valley encephalitis flavivirus, tick flavivirus and yellow fever flavivirus can cause severe illness and possibly death. Mosquitoes and ticks transmit many types of flaviviruses. For example, severe symptoms of West Nile virus infection include high fever, headache, stiff neck, trance, disorientation, lethargy, tremors, convulsions, muscle weakness, vision loss, numbness, meningoencephalomyelitis, and paralysis. These...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/00C07K14/18A61K39/00A61K39/12A61P37/04
CPCC12N2770/24122C07K2319/00A61K39/12A61K2039/6068A61K2039/55594A61K38/00C12N2770/24022C07K14/005C12N2770/24134Y02A50/30
Inventor 汤玛斯·J·普威尔弗利立安·纳卡尔朗秋·尚詹姆士·W·胡利特威廉·F·麦当劳杜安·D·黑威特
Owner VAXINNATE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products